EDGAR Filing Documents for 0001415889-17-001506

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001415889-17-001506

Filing Date

2017-09-18

Accepted

2017-09-18 17:20:42

Documents

Period of Report

2017-09-15

Document Format Files

Seq	Description	Document	Type	Size
1		form4-09182017_050931.html	4
1		form4-09182017_050931.xml	4	4358
	Complete submission text file	0001415889-17-001506.txt		5825

Mailing Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121

Business Address 11535 SORRENTO VALLEY ROAD SUITE 400 SAN DIEGO CA 92121 8582599405

MABVAX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001109196 (see all company filings)

IRS No.: 930987903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11588 SORRENTO VALLEY ROAD, SUITE 20 SAN DIEGO CA 92121

Business Address

Type: 4 | Act: 34 | File No.: 001-37861 | Film No.: 171090511